TransThera Biosciences

About:

TransThera Biosciences is a biotech company that specializes in the treatment of oncology, cardiovascular, and inflammatory diseases.

Website: http://transtherabio.com/en/newsview.aspx?class=179&id=26

Top Investors: Co-Stone Venture Capital, China Merchants Venture Capital, Sixty Degree Capital, Morningside Ventures, China Structural Reform Fund

Description:

TransThera Biosciences is a biotech company that focuses on the discovery and development of small-molecule new drugs. Its research and business strategies zero in clear unmet medical needs in oncology and inflammatory diseases through internal research and open innovation. The company was founded in 2016 and is headquartered in Nanjing, Jiangsu.

Total Funding Amount:

$148M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nanjing, Jiangsu, China

Founded Date:

2016-01-01

Contact Email:

info(AT)transtherabio.com

Founders:

Frank Wu

Number of Employees:

51-100

Last Funding Date:

2023-02-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai